Surgical access system and related methods

Information

  • Patent Grant
  • 10653308
  • Patent Number
    10,653,308
  • Date Filed
    Wednesday, March 16, 2016
    8 years ago
  • Date Issued
    Tuesday, May 19, 2020
    4 years ago
Abstract
A surgical access system including a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor to a surgical target site. Some embodiments of the surgical access system may be particularly suited for establishing an operative corridor to a surgical target site in the spine. Such an operative corridor may be established through the retroperitoneal space and the psoas muscle during a direct lateral, retroperitoneal approach to the spine.
Description
BACKGROUND OF THE INVENTION
I. Field of the Invention

The present invention relates generally to systems and methods for performing surgical procedures and, more particularly, for accessing a surgical target site in order to perform surgical procedures.


II. Discussion of the Prior Art

A noteworthy trend in the medical community is the move away from performing surgery via traditional “open” techniques in favor of minimally invasive or minimal access techniques. Open surgical techniques are generally undesirable in that they typically require large incisions and high amounts of tissue displacement to gain access to the surgical target site, which produces concomitantly high amounts of pain, lengthened hospitalization (increasing health care costs), and high morbidity in the patient population. Less-invasive surgical techniques (including so-called “minimal access” and “minimally invasive” techniques) are gaining favor due to the fact that they involve accessing the surgical target site via incisions of substantially smaller size with greatly reduced tissue displacement requirements. This, in turn, reduces the pain, morbidity and cost associated with such procedures. The access systems developed to date, however, fail in various respects to meet all the needs of the surgeon population.


One drawback associated with prior art surgical access systems relates to the ease with which the operative corridor can be created, as well as maintained over time, depending upon the particular surgical target site. For example, when accessing surgical target sites located beneath or behind musculature or other relatively strong tissue (such as, by way of example only, the psoas muscle adjacent to the spine), it has been found that advancing an operative corridor-establishing instrument directly through such tissues can be challenging and/or lead to unwanted or undesirable effects (such as stressing or tearing the tissues). While certain efforts have been undertaken to reduce the trauma to tissue while creating an operative corridor, such as (by way of example only) the sequential dilation system of U.S. Pat. No. 5,792,044 to Foley et al., these attempts are nonetheless limited in their applicability based on the relatively narrow operative corridor. More specifically, based on the generally cylindrical nature of the so-called “working cannula,” the degree to which instruments can be manipulated and/or angled within the cannula can be generally limited or restrictive, particularly if the surgical target site is a relatively deep within the patient.


Efforts have been undertaken to overcome this drawback, such as shown in U.S. Pat. No. 6,524,320 to DiPoto, wherein an expandable portion is provided at the distal end of a cannula for creating a region of increased cross-sectional area adjacent to the surgical target site. While this system may provide for improved instrument manipulation relative to sequential dilation access systems (at least at deep sites within the patient), it is nonetheless flawed in that the deployment of the expandable portion may inadvertently compress or impinge upon sensitive tissues adjacent to the surgical target site. For example, in anatomical regions having neural and/or vasculature structures, such a blind expansion may cause the expandable portion to impinge upon these sensitive tissues and cause neural and/or vasculature compromise, damage and/or pain for the patient.


This highlights yet another drawback with the prior art surgical access systems, namely, the challenges in establishing an operative corridor through or near tissue having major neural structures which, if contacted or impinged, may result in neural impairment for the patient. Due to the threat of contacting such neural structures, efforts thus far have largely restricted to establishing operative corridors through tissue having little or substantially reduced neural structures, which effectively limits the number of ways a given surgical target site can be accessed. This can be seen, by way of example only, in the spinal arts, where the exiting nerve roots and neural plexus structures in the psoas muscle have rendered a lateral or far lateral access path (so-called trans-psoas approach) to the lumbar spine virtually impossible. Instead, spine surgeons are largely restricted to accessing the spine from the posterior (to perform, among other procedures, posterior lumbar interbody fusion (PLIF)) or from the anterior (to perform, among other procedures, anterior lumbar interbody fusion (ALIF)).


Posterior-access procedures involve traversing a shorter distance within the patient to establish the operative corridor, albeit at the price of oftentimes having to reduce or cut away part of the posterior bony structures (i.e. lamina, facets, spinous process) in order to reach the target site (which typically comprises the disc space). Anterior-access procedures are relatively simple for surgeons in that they do not involve reducing or cutting away bony structures to reach the surgical target site. However, they are nonetheless disadvantageous in that they require traversing through a much greater distance within the patient to establish the operative corridor, oftentimes requiring an additional surgeon to assist with moving the various internal organs out of the way to create the operative corridor.


The present invention is directed at eliminating, or at least minimizing the effects of, the above-identified drawbacks in the prior art.


SUMMARY OF THE INVENTION

The present invention accomplishes this goal by providing a novel access system and related methods which involve detecting the existence of (and optionally the distance and/or direction to) neural structures before, during, and after the establishment of an operative corridor through (or near) any of a variety of tissues having such neural structures which, if contacted or impinged, may otherwise result in neural impairment for the patient. It is expressly noted that, although described herein largely in terms of use in spinal surgery, the access system of the present invention is suitable for use in any number of additional surgical procedures wherein tissue having significant neural structures must be passed through (or near) in order to establish an operative corridor.


According to one broad aspect of the present invention, the access system comprises a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures. The tissue distraction assembly (in conjunction with one or more elements of the tissue retraction assembly) is capable of, as an initial step, distracting a region of tissue between the skin of the patient and the surgical target site. The tissue retraction assembly is capable of, as a secondary step, being introduced into this distracted region to thereby define and establish the operative corridor. Once established, any of a variety of surgical instruments, devices, or implants may be passed through and/or manipulated within the operative corridor depending upon the given surgical procedure. The electrode(s) are capable of, during both tissue distraction and retraction, detecting the existence of (and optionally the distance and/or direction to) neural structures such that the operative corridor may be established through (or near) any of a variety of tissues having such neural structures which, if contacted or impinged, may otherwise result in neural impairment for the patient. In this fashion, the access system of the present invention may be used to traverse tissue that would ordinarily be deemed unsafe or undesirable, thereby broadening the number of manners in which a given surgical target site may be accessed.


The tissue distraction assembly may include any number of components capable of performing the necessary distraction. By way of example only, the tissue distraction assembly may include a K-wire, an initial dilator of split construction, and one or more dilators of traditional (that is, non-split) construction for performing the necessary tissue distraction to receive the remainder of the tissue retractor assembly thereafter. One or more electrodes may be provided on one or more of the K-wire and dilator(s) to detect the presence of (and optionally the distance and/or direction to) neural structures during tissue distraction.


The tissue retraction assembly may include any number of components capable of performing the necessary retraction. By way of example only, the tissue retraction assembly may include one or more retractor blades extending from a handle assembly. The handle assembly may be manipulated to open the retractor assembly; that is, allowing the retractor blades to separate from one another (simultaneously or sequentially) to create an operative corridor to the surgical target site. In a preferred embodiment, this is accomplished by maintaining a posterior retractor blade in a fixed position relative to the surgical target site (so as to avoid having it impinge upon any exiting nerve roots near the posterior elements of the spine) while the additional retractor blades (i.e. cephalad-most and caudal-most blades) are moved or otherwise translated away from the posterior retractor blade (and each other) so as to create the operative corridor in a fashion that doesn't infringe upon the region of the exiting nerve roots.


The retractor blades may be optionally dimensioned to receive and direct a rigid shim element to augment the structural stability of the retractor blades and thereby ensure the operative corridor, once established, will not decrease or become more restricted, such as may result if distal ends of the retractor blades were permitted to “slide” or otherwise move in response to the force exerted by the displaced tissue. In a preferred embodiment, only the posterior retractor blade is equipped with such a rigid shim element. In an optional aspect, this shim element may be advanced into the disc space after the posterior retractor blade is positioned, but before the retractor is opened into the fully retracted position. The rigid shim element is preferably oriented within the disc space such that is distracts the adjacent vertebral bodies, which serves to restore disc height. It also preferably advances a sufficient distance within the disc space (preferably past the midline), which serves the dual purpose of preventing post-operative scoliosis and forming a protective barrier (preventing the migration of tissue (such as nerve roots) into the operative field and the inadvertent advancement of instruments outside the operative field).


The retractor blades may optionally be equipped with a mechanism for transporting or emitting light at or near the surgical target site to aid the surgeon's ability to visualize the surgical target site, instruments and/or implants during the given surgical procedure. According to one embodiment, this mechanism may comprise, but need not be limited to, coupling one or more light sources to the retractor blades such that the terminal ends are capable of emitting light at or near the surgical target site. According to another embodiment, this mechanism may comprise, but need not be limited to, constructing the retractor blades of suitable material (such as clear polycarbonate) and configuration such that light may be transmitted generally distally through the walls of the retractor blade light to shine light at or near the surgical target site. This may be performed by providing the retractor blades having light-transmission characteristics (such as with clear polycarbonate construction) and transmitting the light almost entirely within the walls of the retractor blade (such as by frosting or otherwise rendering opaque portions of the exterior and/or interior) until it exits a portion along the interior (or medially-facing) surface of the retractor blade to shine at or near the surgical target site. The exit portion may be optimally configured such that the light is directed towards the approximate center of the surgical target site and may be provided along the entire inner periphery of the retractor blade or one or more portions therealong.


According to another aspect of the invention, a minimally invasive lateral lumber surgery may be performed using various embodiments of the surgical access system. The surgical method may be accomplished by guiding at least a portion of the tissue distraction assembly to the surgical target site using a lateral, retroperitoneal approach. According to some embodiments, the access system is used to access the lumbar spine via a direct lateral, retroperitoneal approach. In such embodiments, blunt finger dissection may be used to safely enter the retroperitoneal space posteriorly and sweep the peritoneal cavity anteriorly. A distal end of the K-wire, and possibly other components of the tissue distraction assembly, are then escorted through the retroperitoneal space to the psoas muscle utilizing finger dissection. In some instances, the initial dilator is guided through the retroperitoneal space by a finger in contact with the distal end, so the potential of peritoneal disruption may be reduced.





BRIEF DESCRIPTION OF THE DRAWINGS

Many advantages of the present invention will be apparent to those skilled in the art with a reading of this specification in conjunction with the attached drawings, wherein like reference numerals are applied to like elements and wherein:



FIG. 1 is a perspective view of a tissue retraction assembly (in use) forming part of a surgical access system according to the present invention;



FIGS. 2-3 are perspective views illustrating the front and back of a shim element for use with a posterior retractor blade of the retractor according to the retractor of the present invention;



FIGS. 4-5 are perspective views illustrating the front and back of a narrow retractor extender for use with one of a cephalad and caudal retractor blade according to the retractor of the present invention;



FIGS. 6-7 are perspective views illustrating the front and back of a wide retractor extender for use with one of a cephalad and caudal retractor blade according to the retractor of the present invention;



FIG. 8 is a perspective, partially exploded view of the retractor assembly of the present invention, without the retractor blades;



FIG. 9 is a perspective view illustrating the components and use of an initial distraction assembly (i.e. K-wire, an initial dilating cannula with handle, and a split-dilator housed within the initial dilating cannula) forming part of the surgical access system according to the present invention, for use in distracting to a surgical target site (i.e. annulus);



FIG. 10 is a perspective view illustrating the K-wire and split-dilator of the initial distraction assembly with the initial dilating cannula and handle removed;



FIG. 11 is a posterior view of the vertebral target site illustrating the split-dilator of the present invention in use distracting in a generally cephalad-caudal fashion according to one aspect of the present invention;



FIG. 12 is a side view illustrating the use of a secondary distraction assembly (comprising a plurality of dilating cannulae over the K-wire) to further distract tissue between the skin of the patient and the surgical target site according to the present invention;



FIG. 13 is a side view of a retractor assembly according to the present invention, comprising a handle assembly having three (3) retractor blades extending there from (posterior, cephalad-most, and caudal-most) disposed over the secondary distraction assembly of FIG. 12 (shown in a first, closed position);



FIG. 14 is a side view of a retractor assembly according to the present invention, comprising a handle assembly having three (3) retractor blades extending there from (posterior, cephalad-most, and caudal-most) with the secondary distraction assembly of FIG. 12 removed and shim element introduced;



FIGS. 15-16 are perspective and top views, respectively, of the retractor assembly in a second, opened (i.e. retracted) position to thereby create an operative corridor to a surgical target site according to the present invention;



FIGS. 17-18 are perspective and side views, respectively, of the retractor assembly in the second, opened (i.e. retracted) position (with the secondary distraction assembly removed) and with the retractor extenders of FIGS. 4-5 and 6-7 coupled to the retractor according to the present invention.



FIG. 19 is a perspective view of an exemplary nerve monitoring system capable of performing nerve monitoring before, during and after the creating of an operative corridor to a surgical target site using the surgical access system in accordance with the present invention;



FIG. 20 is a block diagram of the nerve monitoring system shown in FIG. 19; and



FIGS. 21-22 are screen displays illustrating exemplary features and information communicated to a user during the use of the nerve monitoring system of FIG. 19.



FIGS. 23-50 illustrate a method for accessing a surgical target site in the spine using a substantially lateral, retroperitoneal approach.





DESCRIPTION OF THE PREFERRED EMBODIMENT

Illustrative embodiments of the invention are described below. In the interest of clarity, not all features of an actual implementation are described in this specification. It will of course be appreciated that in the development of any such actual embodiment, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which will vary from one implementation to another. Moreover, it will be appreciated that such a development effort might be complex and time-consuming, but would nevertheless be a routine undertaking for those of ordinary skill in the art having the benefit of this disclosure. It is furthermore to be readily understood that, although discussed below primarily within the context of spinal surgery, the surgical access system of the present invention may be employed in any number of anatomical settings to provide access to any number of different surgical target sites throughout the body. The surgical access system disclosed herein boasts a variety of inventive features and components that warrant patent protection, both individually and in combination.


The present invention involves accessing a surgical target site in a fashion less invasive than traditional “open” surgeries and doing so in a manner that provides access in spite of the neural structures required to be passed through (or near) in order to establish an operative corridor to the surgical target site. Generally speaking, the surgical access system of the present invention accomplishes this by providing a tissue distraction assembly and a tissue retraction assembly, both of which may be equipped with one or more electrodes for use in detecting the existence of (and optionally the distance and/or direction to) neural structures. In some embodiments, the surgical access system may be used access a surgical target site on the spine via a substantially lateral, retroperitoneal approach (as shown, for example, in FIGS. 23-50).


These electrodes are preferably provided for use with a nerve surveillance system such as, by way of example, the type shown and described in the co-pending and commonly assigned NeuroVision PCT Applications referenced above, the entire contents of which are expressly incorporated by reference as if set forth herein in their entirety. Generally speaking, this nerve surveillance system is capable of detecting the existence of (and optionally the distance and/or direction to) neural structures during the distraction and retraction of tissue by detecting the presence of nerves by applying a stimulation signal to such instruments and monitoring the evoked EMG signals from the myotomes associated with the nerves being passed by the distraction and retraction systems of the present invention. In so doing, the system as a whole (including the surgical access system of the present invention) may be used to form an operative corridor through (or near) any of a variety of tissues having such neural structures, particularly those which, if contacted or impinged, may otherwise result in neural impairment for the patient. In this fashion, the access system of the present invention may be used to traverse tissue that would ordinarily be deemed unsafe or undesirable, thereby broadening the number of manners in which a given surgical target site may be accessed.


The tissue distraction assembly of the present invention (comprising a K-wire, an initial dilator, and a split-dilator disposed within the initial dilator) is employed to distract the tissues extending between the skin of the patient and a given surgical target site (preferably along the posterior region of the target intervertebral disc). A secondary distraction assembly (i.e. a plurality of sequentially dilating cannulae) may optionally be employed after the initial distraction assembly to further distract the tissue. Once distracted, the resulting void or distracted region within the patient is of sufficient size to accommodate a tissue retraction assembly of the present invention. More specifically, the tissue retraction assembly (comprising a plurality of retractor blades extending from a handle assembly) may be advanced relative to the secondary distraction assembly such that the retractor blades, in a first, closed position, are advanced over the exterior of the secondary distraction assembly. At that point, the handle assembly may be operated to move the retractor blades into a second, open or “retracted” position to create an operative corridor to the surgical target site.


According to one aspect of the invention, following (or before) this retraction, a posterior shim element (which is preferably slideably engaged with the posterior retractor blade) may be advanced such that a distal shim extension in positioned within the posterior region of the disc space. If done before retraction, this helps ensure that the posterior retractor blade will not move posteriorly during the retraction process, even though the other retractor blades (i.e. cephalad-most and caudal-most) are able to move and thereby create an operative corridor. Fixing the posterior retractor blade in this fashion serves several important functions. First, the distal end of the shim element serves to distract the adjacent vertebral bodies, thereby restoring disc height. It also rigidly couples the posterior retractor blade in fixed relation relative to the vertebral bodies. The posterior shim element also helps ensure that surgical instruments employed within the operative corridor are incapable of being advanced outside the operative corridor, preventing inadvertent contact with the exiting nerve roots during the surgery. Once in the appropriate retracted state, the cephalad-most and caudal-most retractor blades may be locked in position and, thereafter, retractor extenders advanced therealong to prevent the ingress or egress of instruments or biological structures (i.e. nerves, vasculature, etc. . . . ) into or out of the operative corridor. Once the operative corridor is established, any of a variety of surgical instruments, devices, or implants may be passed through and/or manipulated within the operative corridor depending upon the given surgical procedure.



FIG. 1 illustrates a tissue retraction assembly 10 forming part of a surgical access system according to the present invention. The retraction assembly 10 includes a plurality of retractor blades extending from a handle assembly 20. By way of example only, the handle assembly 20 is provided with a first retractor blade 12, a second retractor blade 16, and a third retractor blade 18. The retractor assembly 10 is shown in a fully retracted or “open” configuration, with the retractor blades 12, 16, 18 positioned a distance from one another so as to form an operative corridor 15 there between and extending to a surgical target site (e.g. an annulus of an intervertebral disc). Although shown and described below with regard to the three-bladed configuration, it is to be readily appreciated that the number of retractor blades may be increased or decreased without departing from the scope of the present invention. Moreover, although described and shown herein, for example in FIGS. 1, 9-18, and 23-50, with reference to a generally lateral approach to a spinal surgical target site (with the first blade 12 being the “posterior” blade, the second blade 16 being the “cephalad-most” blade, and the third blade 18 being the “caudal-most” blade), it will be appreciated that the retractor assembly 10 of the present invention may find use in any number of different surgical approaches, including generally posterior, generally postero-lateral, generally anterior and generally antero-lateral.


The retractor blades 12, 16, 18 may be equipped with various additional features or components. By way of example only, posterior retractor blade 12 may be equipped with a shim element 22 (shown more clearly in FIGS. 2-3). Shim element 22 serves to distract the adjacent vertebral bodies (thereby restoring disc height), helps secure the retractor assembly 10 relative to the surgical target site, and forms a protective barrier to prevent the ingress or egress of instruments or biological structures (i.e. nerves, vasculature, etc. . . . ) into or out of the operative corridor. Each of the remaining retractor blades (cephalad-most blade 16 and caudal-most blade 18) may be equipped with a retractor extender, such as the narrow retractor extender 24 shown in FIGS. 4-5 or the wide retractor extender 25 shown in FIGS. 6-7. The retractor extenders 24/25 extend from the cephalad-most and caudal-most retractor blades 16, 18 to form a protective barrier to prevent the ingress or egress of instruments or biological structures (i.e. nerves, vasculature, etc. . . . ) into or out of the operative corridor 15.


According to the present invention, any or all of the retractor blades 12, 16, 18, the shim element 22 and/or the retractor extenders 24/25 may be provided with one or more electrodes 39 (preferably at their distal regions) equipped for use with a nerve surveillance system, such as, by way of example, the type shown and described in the NeuroVision PCT Applications. Each of the shim element 22 and/or the retractor extenders 24/25 may also be equipped with a mechanism to selectively and releasably engage with the respective retractor blades 12, 16, 18. By way of example only, this may be accomplished by configuring the shim element 22 and/or the retractor extenders 24/25 with a tab element 27 capable of engaging with corresponding rachet-like grooves (shown at 29 in FIG. 1) along the inner-facing surfaces of the retractor blades 12, 16, 18. Each of the shim element 22 and/or the retractor extenders 24/25 is provided with a pair of engagement elements 37 having, by way of example only, a generally dove-tailed cross-sectional shape. The engagement elements 37 are dimensioned to engage with receiving portions on the respective retractor blades 12, 16, 18. In a preferred embodiment, each of the shim element 22 and/or the retractor extenders 24/25 are provided with an elongate slot 43 for engagement with an insertion tool (not shown). Each tab member 27 is also equipped with an enlarged tooth element 49 which engages within corresponding grooves 29 provided along the inner surface of the retractor blades 12, 16, 18.


The handle assembly 20 may be coupled to any number of mechanisms for rigidly registering the handle assembly 20 in fixed relation to the operative site, such as through the use of an articulating arm mounted to the operating table. The handle assembly 20 includes first and second arm members 26, 28 hingedly coupled via coupling mechanism shown generally at 30. The cephalad-most retractor blade 16 is rigidly coupled (generally perpendicularly) to the end of the first arm member 26. The caudal-most retractor blade 18 is rigidly coupled (generally perpendicularly) to the end of the second arm member 28. The posterior retractor blade 12 is rigidly coupled (generally perpendicularly to) a translating member 17, which is coupled to the handle assembly 20 via a linkage assembly shown generally at 14. The linkage assembly 14 includes a roller member 34 having a pair of manual knob members 36 which, when rotated via manual actuation by a user, causes teeth 35 on the roller member 34 to engage within ratchet-like grooves 37 in the translating member 17. Thus, manual operation of the knobs 36 causes the translating member 17 to move relative to the first and second arm members 26, 28.


Through the use of handle extenders 31, 33 (FIG. 8), the arms 26, 28 may be simultaneously opened such that the cephalad-most and caudal-most retractor blades 16, 18 move away from one another. In this fashion, the dimension and/or shape of the operative corridor 15 may be tailored depending upon the degree to which the translating member 17 is manipulated relative to the arms 26, 28. That is, the operative corridor 15 may be tailored to provide any number of suitable cross-sectional shapes, including but not limited to a generally circular cross-section, a generally ellipsoidal cross-section, and/or an oval cross-section. Optional light emitting devices 39 may be coupled to one or more of the retractor blades 12, 16, 18 to direct light down the operative corridor 15.



FIG. 9 illustrates an initial distraction assembly 40 forming part of the surgical access system according to the present invention. The initial distraction assembly 40 includes a K-wire 42, an initial dilating cannula 44 with handle 46, and a split-dilator 48 housed within the initial dilating cannula 44. In use, the K-wire 42 and split-dilator 48 are disposed within the initial dilating cannula 44 and the entire assembly 40 advanced through the tissue towards the surgical target site (i.e. annulus). One exemplary method for advancing an initial dilator towards a spinal target site is described in more detail later in connection with FIGS. 23-50. Again, this is preferably accomplished while employing the nerve detection and/or direction features described above. After the initial dilating assembly 40 is advanced such that the distal ends of the split-dilator 48 and initial dilator 44 are positioned within the disc space (FIG. 9), the initial dilator 44 and handle 46 are removed (FIG. 10) to thereby leave the split-dilator 48 and K-wire 42 in place. As shown in FIG. 11, the split-dilator 48 is thereafter split such that the respective halves 48a, 48b are separated from one another to distract tissue in a generally cephalad-caudal fashion relative to the target site. The split dilator 48 may thereafter be relaxed (allowing the dilator halves 48a, 48b to come together) and rotated such that the dilator halves 48a, 48b are disposed in the anterior-posterior plane. Once rotated in this manner, the dilator halves 48a, 48b are again separated to distract tissue in a generally anterior-posterior fashion. Each dilator halve 48a, 48b may be, according to the present invention, provided with one or more electrodes (preferably at their distal regions) equipped for use with a nerve surveillance system, such as, by way of example, the type shown and described in the NeuroVision PCT Applications.


Following this initial distraction, a secondary distraction may be optionally undertaken, such as via a sequential dilation system 50 as shown in FIG. 12. According to the present invention, the sequential dilation system 50 may include the K-wire 42, the initial dilator 44, and one or more supplemental dilators 52, 54 for the purpose of further dilating the tissue down to the surgical target site. Once again, each component of the secondary distraction assembly 50 (namely, the K-wire 42, the initial dilator 44, and the supplemental dilators 52, 54 may be, according to the present invention, provided with one or more electrodes (preferably at their distal regions) equipped for use with a nerve surveillance system, such as, by way of example, the type shown and described in the NeuroVision PCT Applications.


As shown in FIG. 13, the retraction assembly 10 of the present invention is thereafter advanced along the exterior of the sequential dilation system 50. This is accomplished by maintaining the retractor blades 12, 16, 18 in a first, closed position (with the retractor blades 12-16 in generally abutting relation to one another). Once advanced to the surgical target site, the sequential dilation assembly 50 may be removed and the shim element 22 engaged with the posterior retractor blade 12 such that the distal end thereof extends into the disc space as shown in FIG. 14. At this point, the handle assembly 20 may be operated to move the retractor blades 16, 18 into a second, open or “retracted” position as shown generally in FIGS. 15-16. As one can see, the posterior retractor blade 12 is allowed to stay in the same general position during this process, such that the cephalad-most and caudal-most retractor blades 14, 16 move away from the posterior retractor blade 12. At this point, the narrow and wide retractor extenders 24, 25 may be engaged with the caudal-most retractor blade 18 and cephalad-most retractor blade 16, respectively, as shown in FIGS. 17-18.


As mentioned above, any number of distraction components and/or retraction components (including but not limited to those described herein) may be equipped to detect the presence of (and optionally the distance and/or direction to) neural structures during the steps tissue distraction and/or retraction. This is accomplished by employing the following steps: (1) one or more stimulation electrodes are provided on the various distraction and/or retraction components; (2) a stimulation source (e.g. voltage or current) is coupled to the stimulation electrodes; (3) a stimulation signal is emitted from the stimulation electrodes as the various components are advanced towards or maintained at or near the surgical target site; and (4) the patient is monitored to determine if the stimulation signal causes muscles associated with nerves or neural structures within the tissue to innervate. If the nerves innervate, this may indicate that neural structures may be in close proximity to the distraction and/or retraction components.


Neural monitoring may be accomplished via any number of suitable fashions, including but not limited to observing visual twitches in muscle groups associated with the neural structures likely to found in the tissue, as well as any number of monitoring systems, including but not limited to any commercially available “traditional” electromyography (EMG) system (that is, typically operated by a neurophysiologist). Such monitoring may also be carried out via the surgeon-driven EMG monitoring system shown and described in the following commonly owned and co-pending NeuroVision PCT Applications referenced above. In any case (visual monitoring, traditional EMG and/or surgeon-driven EMG monitoring), the access system of the present invention may advantageously be used to traverse tissue that would ordinarily be deemed unsafe or undesirable, thereby broadening the number of manners in which a given surgical target site may be accessed. For example, the surgical access system may be advantageously used to traverse tissue through the retroperitoneal space and the psoas muscle during a substantially lateral, retroperitoneal approach to the lumbar spine, as shown in FIGS. 23-50.



FIGS. 19-20 illustrate, by way of example only, a monitoring system 120 of the type disclosed in the NeuroVision PCT Applications suitable for use with the surgical access system 10 of the present invention. The monitoring system 120 includes a control unit 122, a patient module 124, and an EMG harness 126 and return electrode 128 coupled to the patient module 124, and a cable 132 for establishing electrical communication between the patient module 124 and the surgical access system of the present invention (retractor assembly 10 of FIG. 1 and distraction assemblies 40, 50 of FIGS. 9-12). More specifically, this electrical communication can be achieved by providing, by way of example only, a hand-held stimulation controller 152 capable of selectively providing a stimulation signal (due to the operation of manually operated buttons on the hand-held stimulation controller 152) to one or more connectors 156a, 156b, 156c. The connectors 156a, 156b, 156c are suitable to establish electrical communication between the hand-held stimulation controller 152 and (by way of example only) the stimulation electrodes on the K-wire 42, the dilators 44, 48, 52, 54, the retractor blades 12, 16, 18 and/or the shim members 22, 24, 25 (collectively “surgical access instruments”).


In order to use the monitoring system 120, then, these surgical access instruments must be connected to the connectors 156a, 156b and/or 156c, at which point the user may selectively initiate a stimulation signal (preferably, a current signal) from the control unit 122 to a particular surgical access instruments. Stimulating the electrode(s) on these surgical access instruments before, during and/or after establishing operative corridor will cause nerves that come into close or relative proximity to the surgical access instruments to depolarize, producing a response in a myotome associated with the innervated nerve.


The control unit 122 includes a touch screen display 140 and a base 142, which collectively contain the essential processing capabilities (software and/or hardware) for controlling the monitoring system 120. The control unit 122 may include an audio unit 118 that emits sounds according to a location of a surgical element with respect to a nerve. The patient module 124 is connected to the control unit 122 via a data cable 144, which establishes the electrical connections and communications (digital and/or analog) between the control unit 122 and patient module 124. The main functions of the control unit 122 include receiving user commands via the touch screen display 140, activating stimulation electrodes on the surgical access instruments, processing signal data according to defined algorithms, displaying received parameters and processed data, and monitoring system status and report fault conditions. The touch screen display 140 is preferably equipped with a graphical user interface (GUI) capable of communicating information to the user and receiving instructions from the user. The display 140 and/or base 142 may contain patient module interface circuitry (hardware and/or software) that commands the stimulation sources, receives digitized signals and other information from the patient module 124, processes the EMG responses to extract characteristic information for each muscle group, and displays the processed data to the operator via the display 140.


In one embodiment, the monitoring system 120 is capable of determining nerve direction relative to one or more of the K-wire 42, the dilators 44, 48, 52, 54, the retractor blades 12, 16, 18 and/or the shim elements 22, 24, 25 before, during and/or following the creation of an operative corridor to a surgical target site. Monitoring system 120 accomplishes this by having the control unit 122 and patient module 124 cooperate to send electrical stimulation signals to one or more of the stimulation electrodes provided on these instruments. Depending upon the location of the surgical access system 10 within a patient (and more particularly, to any neural structures), the stimulation signals may cause nerves adjacent to or in the general proximity of the surgical access system 10 to depolarize. This causes muscle groups to innervate and generate EMG responses, which can be sensed via the EMG harness 126. The nerve direction feature of the system 120 is based on assessing the evoked response of the various muscle myotomes monitored by the system 120 via the EMG harness 126.


By monitoring the myotomes associated with the nerves (via the EMG harness 126 and recording electrode 127) and assessing the resulting EMG responses (via the control unit 122), the surgical access system 10 is capable of detecting the presence of (and optionally the distant and/or direction to) such nerves. This provides the ability to actively negotiate around or past such nerves to safely and reproducibly form the operative corridor to a particular surgical target site, as well as monitor to ensure that no neural structures migrate into contact with the surgical access system 10 after the operative corridor has been established. In spinal surgery, for example, this is particularly advantageous in that the surgical access system 10 may be particularly suited for establishing an operative corridor to an intervertebral target site in a postero-lateral, trans-psoas fashion so as to avoid the bony posterior elements of the spinal column. For example, one such operative corridor to an intervertebral target site may be established through the retroperitoneal space and the psoas muscle during a substantially lateral, retroperitoneal approach to the lumbar spine, as shown in FIGS. 23-50.



FIGS. 21-22 are exemplary screen displays (to be shown on the display 140) illustrating one embodiment of the nerve direction feature of the monitoring system shown and described with reference to FIGS. 19-20. These screen displays are intended to communicate a variety of information to the surgeon in an easy-to-interpret fashion. This information may include, but is not necessarily limited to, a display of the function 180 (in this case “DIRECTION”), a graphical representation of a patient 181, the myotome levels being monitored 182, the nerve or group associated with a displayed myotome 183, the name of the instrument being used 184 (in this case, a dilator 46, 48), the size of the instrument being used 185, the stimulation threshold current 186, a graphical representation of the instrument being used 187 (in this case, a cross-sectional view of a dilator 44, 48) to provide a reference point from which to illustrate relative direction of the instrument to the nerve, the stimulation current being applied to the stimulation electrodes 188, instructions for the user 189 (in this case, “ADVANCE” and/or “HOLD”), and (in FIG. 22) an arrow 190 indicating the direction from the instrument to a nerve. This information may be communicated in any number of suitable fashions, including but not limited to the use of visual indicia (such as alpha-numeric characters, light-emitting elements, and/or graphics) and audio communications (such as a speaker element). Although shown with specific reference to a dilating cannula (such as at 184), it is to be readily appreciated that the present invention is deemed to include providing similar information on the display 140 during the use of any or all of the various instruments forming the surgical access system 10 of the present invention, including the initial distraction assembly 40 (i.e. the K-wire 42 and dilators 44, 48) and/or the retractor blades 12, 16, 18 and/or the shim elements 22, 24, 25.


Referring now to FIGS. 23-50, some embodiments of the surgical access system 10 may be particularly suited for establishing an operative corridor to a surgical target site in the spine. Such an operative corridor may be established through the retroperitoneal space and the psoas muscle during a direct lateral, retroperitoneal approach to the spine. A surgeon may have direct visualization of the patient's anatomy without the cumbersome requirements associated with using endoscopes or operating coaxial through narrow tubes. Moreover, when using the access system 10 through a lateral approach to the spine, the potential of damaging nerves while advancing instruments through the psoas muscle may be substantially reduced. It will, of course, be appreciated that the surgical access system and related methods of the present invention may find applicability in any of a variety of surgical and/or medical applications such that the following description relative to the direct lateral, retroperitoneal approach to the spine is not to be limiting of the overall scope of the present invention.


When accessing a spinal target site via the substantially lateral, retroperitoneal approach described in connection with FIGS. 23-50, the surgeon should consider several anatomical reference points, such as the iliac crest, the twelfth rib, and the lateral border of the erector spinae muscle groups. In certain embodiments, blunt finger dissection is used to pass between these muscle groups and access the retroperitoneal space. Such a technique offers simple access to the retroperitoneal space while minimizing the potential of visceral lesion. Furthermore, in such embodiments, the finger may be used to escort one or more dilators through the retroperitoneal space, thus reducing the potential of peritoneal disruption. In some instances, each dilator is preferably advanced through the psoas muscle between the middle and anterior third of the muscle so that the nerves of the lumbar plexus are located posterior and outside the operative corridor. A monitoring system 120 of the type disclosed in the NeuroVision PCT Applications may be used to avoid damage to any peripheral nerves embedded throughout the psoas muscle as the dilator is advanced through the muscle to the surgical target site in the spine.


Referring now to FIGS. 23-24, a patient 200 is positioned on a surgical table 250 in preparation of spinal surgery. In some embodiments, a cushion 252 is positioned between the patient's lateral side and the surgical table 250 to arrange the patient 200 in such a way as to increase the distance between the patient's iliac crest 202 and rib cage 204. Alternatively, a flexion of the surgical table 250 may be used to accomplish the desired arrangement. Such an arrangement helps to open the invertebral disc space 206 at or near the surgical target site.


Referring to FIG. 25, an articulating arm assembly 60 is coupled to the surgical table 250 to maintain the access system 10 in a substantially fixed position relative to the surgical target site when the operative corridor has been established. In this embodiment, the articulating arm assembly 60 is mounted to a bedrail 254 of the surgical table 250. In some instances, a fluoroscopy system 260 is disposed proximal to the surgical table 250 to provide the surgeon with visualization of the surgical target area. This fluoroscopy system 260 includes a display monitor 262 that is positioned such that the surgeon may view the monitor 262 during the operation. In addition, a monitoring system 120 of the type disclosed in the NeuroVision PCT Applications may be positioned near the surgical table 250 so that the surgeon may view a display 140 of the monitoring system 120 during the operation.


Referring now to FIGS. 26-28, one or more instruments, such as K-wires 42, are positioned laterally over an area of the patient 200 and then viewed using the lateral fluoroscopy. The instruments are used to identify a lateral incision location 208 that is substantially lateral to the surgical target site (e.g., the invertebral disc space 206). As shown in FIG. 28, a first mark is made on the patient 200 at the lateral incision location 208. In addition, a second mark is made on the patient at a posteriolateral incision location 209 near the lateral incision location 208. In this embodiment, the posteriolateral incision location 209 is approximately at the lateral border of the erector spine muscle. Preferably, the posteriolateral incision location 209 is within a finger's length of the lateral incision location 208.


Referring to FIG. 29, an incision is made at the posteriolateral incision location 209, and the subcutaneous layers 210 are dissected until reaching the muscular masses 212. A dissection instrument, such as blunt dissection scissors 270, is used to spread the muscle fibers 212 until the retroperitoneal space 215 is reached. Preferably, the surgeon uses great caution to avoid perforation of the peritoneum 214.


Referring to FIGS. 30-31, after the retroperitoneal space 215 is reached, a guide member 275 is inserted through the posteriolateral incision 209 into the retroperitoneal space 215. In a presently preferred embodiment, the guide member is a finger 275 of the surgeon, which is preferably covered with a surgical glove for hygienic purposes. In other embodiments, the guide member 275 may be an instrument or tool configured to extend and maneuver in the retroperitoneal space as described herein. As shown in FIGS. 30-31, the finger 275 may sweep a portion of the retroperitoneal space 215 and then palpate down to the psoas muscle 220. This motion of the finger 275 in the retroperitoneal space 215 may loosen some fatty tissue before a dilator is advanced therethrough.


Referring to FIGS. 32-33, after the psoas muscle 220 is identified, the finger 275 is swept away from the psoas muscle 220 toward the lateral incision location 208. A scalpel 272 or other like instrument is used to make and incision at this location 208. The incision should be of a sufficient size to receive a distal end 41 an initial dilator 40.


Referring to FIGS. 34-35, the finger 275 is used to direct the distal end 41 of the initial dilator 40 through the retroperitoneal space 215 toward the psoas muscle 220. In the presently preferred embodiment, the initial dilator 40 includes at least a K-wire 42 and may also include a split-dilator 48 slideably passed over the K-wire 42 (see, for example, FIG. 10). As shown in FIG. 34, the distal end 41 is introduced through the lateral incision location 208 and directed to the finger 275 in the retroperitoneal space 215. As shown in FIG. 35, the finger 275 engages the initial dilator 40 proximal to the distal end 41 and guides the distal end 41 to the psoas muscle 220. By escorting the dilator 40 through the retroperitoneal space 215 using the finger 275, the potential for breaching or disrupting the peritoneal is reduced. Upon reaching the psoas muscle 220, the location of the distal end 41 relative to the target site may be verified using an imaging system, such as an image intensifier.


Referring to FIGS. 36-37, the distal end 41 of the initial dilator 40 is advanced in a substantially lateral direction through the psoas muscle 220 toward the invertebral disc space 206 at or near the surgical target site. In the presently preferred embodiment, the fibers of the psoas muscle 220 are split using blunt dissection and NeuroVision neurophysiologic monitoring of the type disclosed in the NeuroVision PCT Applications. A stimulation connector 156 of the NeuroVision monitoring system 120 (see FIG. 19) is coupled to the initial dilator 40 to provide a stimulation signal 157 as the dilator 40 is advanced through the psoas muscle 220. It should be understood that the stimulation signal 157 is depicted in FIG. 36 for illustrative purposes and is generally not visible.


Descending nerves of the lumbar plexus normally lie in the posterior one-third of the psoas muscle 220. The NeuroVision monitoring system 120 of the type disclosed in the NeuroVision PCT Applications assists with the safe passage by these nerves and/or confirmation of the nerves' posterior location. The NeuroVision monitoring system 120 will continuously search for the stimulus threshold that elicits an EMG response on the myotomes monitored and then reports such thresholds on a display 140 as shown in FIG. 37. As the dilator is advanced through the psoas muscle 220, the stimulus necessary to elicit an EMG response will vary with distance from the nerve. In the presently preferred embodiment, experience has shown that threshold values greater than 10 mA indicate a distance that allows for safe passage through the psoas muscle 220 and continued nerve safety.


Referring to FIGS. 38-40, a K-wire 42 of the initial dilator 40 is introduced into the targeted disc space 206 after the dilator 40 is passed through the psoas muscle 220. Preferably, the position of the distal end 41 of the dilator 40 is confirmed using fluoroscopic imaging before the K-wire 42 is introduced into the disc space 206. After a distal portion of the K-wire 42 is inserted into the targeted disc space 206, depth markings 45 (FIG. 39) on the dilator 40 may be read at the skin level to determine the appropriate length of retractor blades 12, 16, 18 that will be used with the handle assembly 20 of the access system 10. As shown in FIG. 40, the appropriate length blades 12, 16, and 18 may be secured to the handle portion 20 by tightening fasteners with a driver instrument 274.


Referring to FIG. 41, the sequential dilation system 50 (previously described in connection with FIG. 12), including one or more supplemental dilators 52, 54, may be guided over the initial dilator 40 for the purpose of further dilating the tissue down to the surgical target site. In the presently preferred embodiment, the NeuroVision monitoring system 120 of the type disclosed in the NeuroVision PCT Applications is used with the supplemental dilators 52, 54 to provide safe passage through the psoas muscle 220. The initial dilator 40 and the supplemental dilators 52, 54 are advanced through the lateral incision location 208 to the targeted disc space 206 in a substantially lateral direction to create a distraction corridor.


Still referring to FIG. 41, the retractor blades 12, 16, 18 of the access system 10 are introduced over the supplemental dilator 54 (or the initial dilator 40 if the sequential dilation system 50 is not employed) toward the disc space 206. Again, the NeuroVision monitoring system 120 of the type disclosed in the NeuroVision PCT Applications may be used with the blades 12, 16, 18 to provide safe passage through the psoas muscle 220. In some embodiments, the posterior shim element 22 and/or the retractor extenders 24, 25 are engaged with the retractor blades 12, 16, 18 (as previously described in connection with FIGS. 1-7). After the retractor blades 12, 16, 18 are introduced along the distraction corridor, fluoroscopic imaging may be used to confirm the position of the blades 12, 16, 18 proximal to the disc space 206.


Referring to FIG. 42, the articulating arm assembly 60 is coupled to the handle member 20 of the access system 10. As previous described in connection with FIG. 25, the articulating arm assembly 60 is also coupled to the surgical table 250 so as to maintain the access system 10 in a substantially fixed position. Handles 62 and 64 may be turned to substantially fix the position of articulating arm assembly 60.


Referring now to FIGS. 43-44, handle extenders 31 and 33 may be squeeze to spread the blades 12, 16, 18 and knob members 36 may be turned to selectively adjust the posterior retractor blade 12 (previously described in connection with FIGS. 13-18). Such movement by the blades 12, 16, 18 retracts the distraction corridor so as to form an operative corridor 15.



FIG. 45 shows a lateral view of the operative corridor 15 down to the targeted disc space 206 in the patient's spine. Light emitting devices 39 may be coupled to one or more of the retractor blades 12, 16, 18 to direct light down the operative corridor 15. In this embodiment, the light emitting devices 39 are coupled to a xenon arthroscopy light source. The surgeon may use direct visualization and/or a NeuroVision probe of the type disclosed in the NeuroVision PCT Applications to confirm that the operative corridor 15 is neurologically clear.


Referring to FIGS. 46-50, various instruments may be inserted through the operative corridor 15 to prepare the targeted disc space 206. In the presently preferred embodiment, the operative corridor 15 has a 15-20 mm annulotomy to provide ample space for the various instruments. In other embodiments, the operative corridor 15 may have other configurations, depending on the surgical task to be performed.


In this embodiment depicted in FIGS. 46-50, the disc space 206 is undergoing a discectomy and insertion of a spinal implant. As shown in FIG. 46, at least one preparation tool 276 such as a disc cutter, pituitary, scraper, curette, or the like is inserted through the operative corridor 15 to prepare the disc space 206. Referring more closely to FIG. 47, one or more sizers 277 are inserted to the disc space 206 to provide appropriate disc height restoration. As shown in FIG. 48, a broach 278 may be used in the disc space 206 to remove osteophytes and to facilitate implant insertion.


Referring now to FIGS. 49-50, an appropriately sized implant 282 is advanced into the disc space 206 with an inserter tool 280. The implant 282 is releasably secured to the inserter tool 280 such that the surgeon may release the implant when it is properly positioned in the disc space 206. The implant may comprise a material that facilitates bone fusion (such as allograft or autograft), and autograft or graft extenders may be used in the disc space 206 after the implant is inserted.


After the procedure on the targeted disc space 206 is complete, the access system 10 is carefully removed from the operative corridor 15. Direct visualization may be used to confirm the absence of significant bleeding in the disc space 206 or the psoas muscle 220. The skin around the operative corridor may be closed using a suturing method, such as a subcuticular suture.


Accordingly, certain methods of using the access system 10 can safely and effectively establish a minimally invasive operative corridor through the retroperitoneal space 215 and the psoas muscle 220 via a direct lateral, retroperitoneal approach to the spine. Such a method allows the surgeon to directly visualize the patient's anatomy without the cumbersome requirements associated with using endoscopes or operating coaxial through narrow, artificial tube. Moreover, when employing such a method to laterally approach the spine, the potential of damaging nerves while advancing dilators and other instruments through the psoas muscle 220 may be substantially reduced.


As evident from the above discussion and drawings, the present invention accomplishes the goal of gaining access a surgical target site in a fashion less invasive than traditional “open” surgeries and, moreover, does so in a manner that provides the ability to access such a surgical target site regardless of the neural structures required to be passed through (or near) in order to establish an operative corridor to the surgical target site. The present invention furthermore provides the ability to perform neural monitoring in the tissue or regions adjacent the surgical target site during any procedures performed after the operative corridor has been established. The surgical access system of the present invention can be used in any of a wide variety of surgical or medical applications, above and beyond the spinal applications discussed herein. Such spinal applications may include any procedure wherein instruments, devices, implants and/or compounds are to be introduced into or adjacent the surgical target site, including but not limited to discectomy, fusion (including PLIF, ALIF, TLIF and any fusion effectuated via a lateral or far-lateral approach and involving, by way of example, the introduction of bone products (such as allograft or autograft) and/or devices having ceramic, metal and/or plastic construction (such as mesh) and/or compounds such as bone morphogenic protein), total disc replacement, etc. . . . ).


Moreover, the surgical access system of the present invention opens the possibility of accessing an increased number of surgical target sites in a “less invasive” fashion by eliminating or greatly reducing the threat of contacting nerves or neural structures while establishing an operative corridor through or near tissues containing such nerves or neural structures. In so doing, the surgical access system of the present invention represents a significant advancement capable of improving patient care (via reduced pain due to “less-invasive” access and reduced or eliminated risk of neural contact before, during, and after the establishment of the operative corridor) and lowering health care costs (via reduced hospitalization based on “less-invasive” access and increased number of suitable surgical target sites based on neural monitoring). Collectively, these translate into major improvements to the overall standard of care available to the patient population, both domestically and overseas.

Claims
  • 1. A method of inserting a spinal implant along a lateral path to a targeted lumbar disc space, the method comprising: while a user's finger is inserted through a skin incision, moving a tip portion of the user's finger through bodily tissue in a retroperitoneal space that is lateral from a psoas muscle and a targeted lumbar disc space and contacting the tip portion of the user's finger with the psoas muscle;after contacting the tip portion of the user's finger with the psoas muscle, advancing a dilator system along a lateral path to the targeted lumbar disc space, the dilator system comprising: a first cannulated dilator that is advanced to the targeted lumbar disc space, one or more sequential dilators that are advanced along the lateral path, wherein the first cannulated dilator comprises a central lumen configured to receive an elongate inner member, and wherein one or more of said first cannulated dilator, said one or more sequential dilators, and said elongate inner member includes a stimulation electrode that outputs electrical stimulation for nerve monitoring when the stimulation electrode is positioned in the lateral path;slidably advancing a multi-blade retractor assembly over an outermost dilator of the dilator system toward the targeted lumbar disc space along the lateral path, the multi-blade retractor assembly including a blade adjuster apparatus and a plurality of retractor blades extending from the blade adjuster apparatus, wherein the plurality of retractor blades are slidably advanced over the outermost dilator while in a first position in which the plurality of retractor blades are configured to simultaneously slide over the outermost dilator of the dilator system, wherein the blade adjuster apparatus is operable to adjust the plurality of retractor blades to a second position in which a first retractor blade is moved away from a second retractor blade;removing at least a portion of the dilator system after the multi-blade retractor assembly is advanced along the lateral path, wherein a lateral operative corridor to the targeted lumbar disc space is at least partially defined by the plurality of retractor blades;inserting a spinal implant that is releasably secured to an inserter tool through the lateral operative corridor maintained by the multi-blade retractor assembly and into the targeted lumbar disc space; andreleasing the spinal implant from the inserter tool when the spinal implant is positioned in the targeted lumbar disc space.
  • 2. The method of claim 1, further comprising moving arm portions of the blade adjuster apparatus so that the plurality of retractor blades are adjusted to the second position before the step of inserting the spinal implant.
  • 3. The method of claim 2, further comprising releasably engaging a fixation element with one of the plurality of retractor blades so that at least a portion of the fixation element extends distally from the one of the plurality of retractor blades and anchors into a portion of the spine.
  • 4. The method of claim 3, wherein the fixation element comprises a posterior shim element that releasably engages with a posterior-most retractor blade of the plurality of retractor blades.
  • 5. The method of claim 3, further comprising releasably engaging retractor blade extenders with corresponding retractor blades of the plurality of retractor blades, the retractor blade extenders being different from the fixation element.
  • 6. The method of claim 1, wherein the step of moving the tip portion of the user's finger through the bodily tissue separates fatty tissue in the retroperitoneal space before the dilator system is advanced into the retroperitoneal space.
  • 7. The method of claim 1, further comprising activating one or more light emitting devices to direct light through the lateral operative corridor toward the targeted lumbar disc space, each of the one or more light emitting device being releasably coupled to a respective one of the plurality of retractor blades.
  • 8. The method of claim 1, further comprising inserting at least one preparation tool through the lateral operative corridor formed by the multi-blade retractor assembly along the lateral path so as to remove a portion of a spinal disc from the targeted lumbar disc space.
  • 9. The method of claim 8, further comprising inserting a sizer instrument into the targeted lumbar disc space before the spinal implant is inserted into the targeted lumbar disc space.
  • 10. The method of claim 1, wherein the blade adjuster apparatus comprises: two pivotable arm portions and a knob element that is rotatable relative to a linear rack member having teeth.
  • 11. The method of claim 1, wherein the elongate inner member is deliverable along the lateral path to the targeted lumbar disc space such that a distal tip portion of the elongate inner member penetrates into an annulus of a spinal disc at the targeted lumbar disc space.
  • 12. The method of claim 1, wherein the elongate inner member comprises a K-wire.
  • 13. The method of claim 1, wherein the first cannulated dilator is advanced to the targeted lumbar disc space together with the elongate inner member received within the central lumen of the first cannulated dilator.
  • 14. The method of claim 1, wherein when the multi-blade retractor assembly is in the first position, each retractor blade of the plurality of retractor blades at least partially abuts a neighboring retractor blade of the plurality of retractor blades.
  • 15. The method of claim 1, wherein the skin incision through which the user's finger is inserted is different from a skin penetration point of the first cannulated dilator.
  • 16. The method of claim 1, wherein the step of advancing the dilator system along the lateral path to the targeted lumbar disc space comprises advancing the dilator system along a trans-psoas path through the psoas muscle.
  • 17. The method of claim 1, wherein the step of slidably advancing the multi-blade retractor assembly along the lateral path comprises advancing the multi-blade retractor assembly along a trans-psoas path through the psoas muscle.
  • 18. The method of claim 1, further comprising: activating a nerve monitoring system that delivers an electrical stimulation signal to the stimulation electrode of the first cannulated dilator during delivery of the first cannulated dilator along the lateral path to the targeted lumbar disc space, the nerve monitoring system detecting neuromuscular responses via a set of sensors in leg muscle myotomes associated with nerves in the vicinity of the targeted lumbar disc space; andduring advancement of the first cannulated dilator along the lateral path to the targeted lumbar disc space, viewing a video display device of the nerve monitoring system that displays a numeric stimulation threshold that changes in response to the detection of said neuromuscular responses via said set of sensor in said leg muscle myotomes.
  • 19. The method of claim 1, further comprising: activating a nerve monitoring system that delivers an electrical stimulation signal to the stimulation electrode of the elongate inner member during delivery of the elongate inner member along the lateral path to the targeted lumbar disc space, the nerve monitoring system detecting neuromuscular responses via a set of sensors in leg muscle myotomes associated with nerves in the vicinity of the targeted lumbar disc space; andduring advancement of the elongate inner member along the lateral path to the targeted lumbar disc space, viewing a video display device of the nerve monitoring system that displays a numeric stimulation threshold that changes in response to the detection of said neuromuscular responses via said set of sensor in said leg muscle myotomes.
  • 20. The method of claim 1, further comprising guiding the elongate inner member through the retroperitoneal space along the lateral path while covering a distal region of the elongate inner member with the tip portion of the user's finger.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/066,098 (filed on Oct. 29, 2013), which is a continuation of U.S. patent application Ser. No. 12/983,627 (filed on Jan. 3, 2011), now U.S. Pat. No. 8,591,432, entitled “Surgical Access System and Related Methods,” which is a continuation of U.S. patent application Ser. No. 12/635,869 (filed on Dec. 11, 2009), now U.S. Pat. No. 8,303,515, entitled “Surgical Access System and Related Methods,” which is a continuation of U.S. patent application Ser. No. 10/967,668 (filed on Oct. 18, 2004), now U.S. Pat. No. 7,905,840, entitled “Surgical Access System and Related Methods,” which claims the benefit of priority from U.S. Provisional Patent Application Ser. No. 60/512,594 (filed on Oct. 17, 2003) entitled “System and Methods for Performing Lateral Lumbar Surgery,” the entire contents of all these prior applications are hereby expressly incorporated by reference into this disclosure as if set forth fully herein. The present application also incorporates by reference the following co-assigned patent applications in their entireties: PCT App. Ser. No. PCT/US02/22247, entitled “System and Methods for Determining Nerve Proximity, Direction, and Pathology During Surgery,” filed on Jul. 11, 2002; PCT App. Ser. No. PCT/US02/30617, entitled “System and Methods for Performing Surgical Procedures and Assessments,” filed on Sep. 25, 2002; PCT App. Ser. No. PCT/US02/35047, entitled “System and Methods for Performing Percutaneous Pedicle Integrity Assessments,” filed on Oct. 30, 2002; and PCT App. Ser. No. PCT/US03/02056, entitled “System and Methods for Determining Nerve Direction to a Surgical Instrument,” filed Jan. 15, 2003 (collectively “NeuroVision PCT Applications”).

US Referenced Citations (564)
Number Name Date Kind
208227 Dorr Sep 1878 A
509226 Kellogg Nov 1893 A
972983 Arthur Oct 1910 A
1003232 Cerbo Oct 1910 A
1044348 Cerbo Jun 1912 A
1328624 Graham Jan 1920 A
1548184 Cameron Aug 1925 A
1919120 O'Connor et al. Jul 1933 A
2594086 Smith Apr 1952 A
2704061 Amspacker Mar 1955 A
2704064 Fizzell et al. Jun 1955 A
2736002 Oriel Feb 1956 A
2808826 Reiner et al. Oct 1957 A
2840082 Salvatore Jun 1958 A
3364929 Ide et al. Jan 1968 A
3664329 Naylor May 1972 A
3682162 Colyer Aug 1972 A
3740839 Otte et al. Jun 1973 A
3785368 McCarthy et al. Jan 1974 A
3803716 Garnier Apr 1974 A
3830226 Staub et al. Aug 1974 A
3957036 Normann May 1976 A
D245789 Shea et al. Sep 1977 S
4099519 Warren Jul 1978 A
4164214 Stark et al. Aug 1979 A
4207897 Lloyd et al. Jun 1980 A
4224949 Scott et al. Sep 1980 A
4226228 Shin et al. Oct 1980 A
4226288 Collins, Jr. Oct 1980 A
4235242 Howson et al. Nov 1980 A
4285347 Hess Aug 1981 A
4291705 Severinghaus et al. Sep 1981 A
4449532 Storz May 1984 A
4461300 Christensen Jul 1984 A
4512351 Pohndorf Apr 1985 A
4515168 Chester et al. May 1985 A
4519403 Dickhudt May 1985 A
4545373 Christoudias Oct 1985 A
4545374 Jacobson Oct 1985 A
4561445 Berke et al. Dec 1985 A
4562832 Wilder et al. Jan 1986 A
4573448 Kambin Mar 1986 A
4592369 Davis et al. Jun 1986 A
4595013 Jones et al. Jun 1986 A
4595018 Rantala Jun 1986 A
4611597 Kraus Sep 1986 A
4616635 Caspar et al. Oct 1986 A
4633889 Talalla Jan 1987 A
4658835 Pohndorf Apr 1987 A
D295445 Freeman Apr 1988 S
4744371 Harris May 1988 A
4753223 Bremer Jun 1988 A
4759377 Dykstra Jul 1988 A
4784150 Voorhies et al. Nov 1988 A
4807642 Brown Feb 1989 A
D300561 Asa et al. Apr 1989 S
4817587 Janese Apr 1989 A
4892105 Prass Jan 1990 A
4913134 Luque Apr 1990 A
4917274 Asa et al. Apr 1990 A
4917704 Frey et al. Apr 1990 A
4926865 Oman May 1990 A
4945896 Gade Aug 1990 A
4950257 Hibbs et al. Aug 1990 A
4962766 Herzon Oct 1990 A
4964411 Johnson et al. Oct 1990 A
5007902 Witt Apr 1991 A
5015247 Michelson May 1991 A
5045054 Hood et al. Sep 1991 A
5052373 Michelson Oct 1991 A
5058602 Brody Oct 1991 A
5081990 Deletis Jan 1992 A
5092344 Lee Mar 1992 A
5127403 Brownlee Jul 1992 A
5161533 Prass et al. Nov 1992 A
5171279 Mathews Dec 1992 A
5178133 Pena Jan 1993 A
5190561 Graber Mar 1993 A
5192327 Brantigan Mar 1993 A
5195541 Obenchain Mar 1993 A
5196015 Neubardt Mar 1993 A
5215100 Spitz et al. Jun 1993 A
5231974 Giglio et al. Aug 1993 A
RE34390 Culver Sep 1993 E
D340521 Heinzelman et al. Oct 1993 S
5255691 Otten Oct 1993 A
5261918 Phillips et al. Nov 1993 A
5282468 Klepinski Feb 1994 A
5284153 Raymond et al. Feb 1994 A
5284154 Raymond et al. Feb 1994 A
5295994 Bonutti Mar 1994 A
5299563 Seton Apr 1994 A
5312417 Wilk May 1994 A
5313956 Knutsson et al. May 1994 A
5313962 Obenchain May 1994 A
5327902 Lemmen Jul 1994 A
5331975 Bonutti Jul 1994 A
5333618 Lekhtman et al. Aug 1994 A
5342384 Sugarbaker Aug 1994 A
5357983 Mathews Oct 1994 A
5375067 Berchin Dec 1994 A
5375594 Cueva Dec 1994 A
5383876 Nardella Jan 1995 A
5395317 Kambin Mar 1995 A
5425772 Brantigan Jun 1995 A
5433739 Sluijter et al. Jul 1995 A
5450845 Alexgaard Sep 1995 A
5458638 Kuslich et al. Oct 1995 A
5472426 Bonati et al. Dec 1995 A
5474057 Makower et al. Dec 1995 A
5474558 Neubardt Dec 1995 A
5480440 Kambin Jan 1996 A
5482038 Ruff Jan 1996 A
5484437 Michelson Jan 1996 A
5487739 Aebischer et al. Jan 1996 A
5509893 Pracas Apr 1996 A
5514153 Bonutti May 1996 A
5540235 Wilson Jul 1996 A
5545222 Bonutti Aug 1996 A
5549656 Reiss Aug 1996 A
5560372 Cory Oct 1996 A
5562736 Ray et al. Oct 1996 A
5566678 Cadwell Oct 1996 A
5569290 McAfee Oct 1996 A
5571149 Liss et al. Nov 1996 A
5579781 Cooke Dec 1996 A
5593429 Ruff Jan 1997 A
5599279 Slotman et al. Feb 1997 A
5630813 Kieturakis May 1997 A
5653761 Pisharodi Aug 1997 A
5653762 Pisharodi Aug 1997 A
5667508 Errico et al. Sep 1997 A
5669909 Zdeblick et al. Sep 1997 A
5671752 Sinderby et al. Sep 1997 A
5681265 Maeda et al. Oct 1997 A
5688223 Rosendahl Nov 1997 A
5707359 Bufalini Jan 1998 A
5711307 Smits Jan 1998 A
5716415 Steffee Feb 1998 A
5720751 Jackson Feb 1998 A
5728046 Mayer et al. Mar 1998 A
5728159 Stroever et al. Mar 1998 A
5741253 Michelson Apr 1998 A
5741261 Moskovitz et al. Apr 1998 A
5759159 Masreliez Jun 1998 A
5762629 Kambin Jun 1998 A
5766252 Henry et al. Jun 1998 A
5772661 Michelson Jun 1998 A
5775331 Raymond et al. Jul 1998 A
5776144 Leysieffer et al. Jul 1998 A
5779642 Nightengale Jul 1998 A
5785658 Benaron Jul 1998 A
5792044 Foley et al. Aug 1998 A
5797854 Hedgecock Aug 1998 A
5797909 Michelson Aug 1998 A
5800550 Sertich Sep 1998 A
5813978 Jako Sep 1998 A
5814073 Bonutti Sep 1998 A
5814084 Grivas et al. Sep 1998 A
5830151 Hadzic et al. Nov 1998 A
5851191 Gozani Dec 1998 A
5851208 Trott Dec 1998 A
5853373 Griffith et al. Dec 1998 A
5860973 Michelson Jan 1999 A
5862314 Jeddeloh Jan 1999 A
5865845 Thalgott Feb 1999 A
5872314 Clinton Feb 1999 A
5885210 Cox Mar 1999 A
5885219 Nightengale Mar 1999 A
5888196 Bonutti Mar 1999 A
5888224 Beckers et al. Mar 1999 A
5891147 Moskovitz et al. Apr 1999 A
5893890 Pisharodi Apr 1999 A
5902231 Foley et al. May 1999 A
5910315 Stevenson et al. Jun 1999 A
5928139 Koros et al. Jul 1999 A
5928158 Aristides Jul 1999 A
5931777 Sava Aug 1999 A
5935131 Bonutti et al. Aug 1999 A
5938688 Schiff Aug 1999 A
5944658 Koros et al. Aug 1999 A
5954769 Rosenlicht Sep 1999 A
5968098 Winslow Oct 1999 A
5976094 Gozani et al. Nov 1999 A
5976146 Ogawa et al. Nov 1999 A
5993474 Ouchi Nov 1999 A
6004262 Putz et al. Dec 1999 A
6004312 Finneran Dec 1999 A
6004326 Castro et al. Dec 1999 A
6007487 Foley et al. Dec 1999 A
6008433 Stone Dec 1999 A
6010520 Pattison Jan 2000 A
6015436 Schoenhoeffer Jan 2000 A
6024696 Hoftman et al. Feb 2000 A
6024697 Pisarik Feb 2000 A
6027456 Feler et al. Feb 2000 A
6033405 Winslow et al. Mar 2000 A
6036638 Nwawka Mar 2000 A
6038469 Karlsson et al. Mar 2000 A
6038477 Kayyali Mar 2000 A
6039761 Li et al. Mar 2000 A
6042582 Ray Mar 2000 A
6045580 Scarborough et al. Apr 2000 A
6048342 Zucherman et al. Apr 2000 A
6050992 Nichols Apr 2000 A
6059829 Schlaepfer et al. May 2000 A
6063088 Winslow May 2000 A
6074343 Nathanson et al. Jun 2000 A
6080105 Spears Jun 2000 A
6083154 Liu et al. Jul 2000 A
6083225 Winslow et al. Jul 2000 A
6095987 Schmulewitz Aug 2000 A
6096080 Nicholson et al. Aug 2000 A
6104957 Alo et al. Aug 2000 A
6104960 Duysens et al. Aug 2000 A
6113638 Williams et al. Sep 2000 A
6120503 Michelson Sep 2000 A
6120506 Kohrs et al. Sep 2000 A
6126660 Dietz Oct 2000 A
6132386 Gozani et al. Oct 2000 A
6132387 Gozani et al. Oct 2000 A
6135965 Turner et al. Oct 2000 A
6139493 Koros et al. Oct 2000 A
6142931 Kaji Nov 2000 A
6146335 Gozani Nov 2000 A
6152871 Foley et al. Nov 2000 A
6159179 Simonson Dec 2000 A
6159211 Boriani et al. Dec 2000 A
6159215 Urbahns et al. Dec 2000 A
6159230 Samuels Dec 2000 A
6161047 King et al. Dec 2000 A
6174311 Branch et al. Jan 2001 B1
6181961 Prass Jan 2001 B1
6187000 Davison et al. Feb 2001 B1
6193756 Studer et al. Feb 2001 B1
6196969 Bester et al. Mar 2001 B1
6200347 Anderson et al. Mar 2001 B1
6206826 Mathews et al. Mar 2001 B1
6206922 Zdeblick et al. Mar 2001 B1
6217509 Foley et al. Apr 2001 B1
6224545 Cocchia et al. May 2001 B1
6224549 Drongelen May 2001 B1
6224607 Michelson May 2001 B1
6224631 Kohrs May 2001 B1
6241771 Gresser et al. Jun 2001 B1
6245082 Gellman et al. Jun 2001 B1
6251140 Marino et al. Jun 2001 B1
6258125 Paul et al. Jul 2001 B1
6259945 Epstein et al. Jul 2001 B1
6264651 Underwood et al. Jul 2001 B1
6266558 Gozani et al. Jul 2001 B1
6273905 Streeter Aug 2001 B1
6277149 Boyle et al. Aug 2001 B1
6292701 Prass et al. Sep 2001 B1
6306100 Prass Oct 2001 B1
6308712 Shaw Oct 2001 B1
6312392 Herzon Nov 2001 B1
6319257 Carignan et al. Nov 2001 B1
6325764 Griffith et al. Dec 2001 B1
6334068 Hacker Dec 2001 B1
6348058 Melkent et al. Feb 2002 B1
6360750 Gerber et al. Mar 2002 B1
6371968 Kogasaka et al. Apr 2002 B1
6371989 Chauvin et al. Apr 2002 B1
6383221 Scarborough et al. May 2002 B1
6395007 Bhatnagar et al. May 2002 B1
6409766 Brett Jun 2002 B1
6416465 Brau Jul 2002 B2
6425859 Foley et al. Jul 2002 B1
6425887 McGuckin et al. Jul 2002 B1
6425901 Zhu et al. Jul 2002 B1
6432048 Francois Aug 2002 B1
6432140 Lin Aug 2002 B1
6440142 Ralph et al. Aug 2002 B1
6442814 Landry et al. Sep 2002 B1
6450952 Rioux et al. Sep 2002 B1
6451015 Rittman, III et al. Sep 2002 B1
6454806 Cohen et al. Sep 2002 B1
6466817 Kaula et al. Oct 2002 B1
6468205 Mollenauer et al. Oct 2002 B1
6468207 Fowler, Jr. Oct 2002 B1
6468311 Boyd et al. Oct 2002 B2
6491724 Ferree Dec 2002 B1
6500116 Knapp Dec 2002 B1
6500128 Marino Dec 2002 B2
6520907 Foley et al. Feb 2003 B1
6524320 DiPoto Feb 2003 B2
6535759 Epstein et al. Mar 2003 B1
D472634 Anderson Apr 2003 S
D472650 Green Apr 2003 S
6564078 Marino et al. May 2003 B1
6579244 Goodwin Jun 2003 B2
6595998 Johnson et al. Jul 2003 B2
6599294 Fuss et al. Jul 2003 B2
6620157 Dabney et al. Sep 2003 B1
6626905 Schmiel et al. Sep 2003 B1
6635086 Lin Oct 2003 B2
6645194 Briscoe et al. Nov 2003 B2
6648895 Burkus et al. Nov 2003 B2
6672019 Wenz et al. Jan 2004 B1
6676703 Biscup Jan 2004 B2
6679833 Smith et al. Jan 2004 B2
6706067 Shimp et al. Mar 2004 B2
6719692 Kleffner et al. Apr 2004 B2
6746484 Liu et al. Jun 2004 B1
6755841 Fraser et al. Jun 2004 B2
6760616 Hoey et al. Jul 2004 B2
6761739 Shepard Jul 2004 B2
6770074 Michelson Aug 2004 B2
6796985 Bolger et al. Sep 2004 B2
6810281 Brock et al. Oct 2004 B2
6819956 DiLorenzo Nov 2004 B2
6824564 Crozet Nov 2004 B2
6829508 Schulman et al. Dec 2004 B2
6830570 Frey et al. Dec 2004 B1
6847849 Mamo et al. Jan 2005 B2
6849047 Goodwin Feb 2005 B2
6855105 Jackson, III et al. Feb 2005 B2
6869398 Obenchain Mar 2005 B2
6871099 Whitehurst et al. Mar 2005 B1
D503801 Jackson Apr 2005 S
6902569 Parmer et al. Jun 2005 B2
6916330 Simonson Jul 2005 B2
6926728 Zucherman et al. Aug 2005 B2
6929606 Ritland Aug 2005 B2
6942698 Jackson Sep 2005 B1
6945933 Branch Sep 2005 B2
6951538 Ritland Oct 2005 B2
6964687 Bernard et al. Nov 2005 B1
6979353 Bresina Dec 2005 B2
6984245 McGahan et al. Jan 2006 B2
6986788 Paul et al. Jan 2006 B2
6989031 Michelson Jan 2006 B2
7018416 Hanson et al. Mar 2006 B2
7047082 Schrom et al. May 2006 B1
7050848 Hoey et al. May 2006 B2
7079883 Marino et al. Jul 2006 B2
7089059 Pless Aug 2006 B1
D530423 Miles et al. Oct 2006 S
7166113 Arambula et al. Jan 2007 B2
7177677 Kaula et al. Feb 2007 B2
7198598 Smith et al. Apr 2007 B2
7207949 Miles et al. Apr 2007 B2
7226451 Shluzas et al. Jun 2007 B2
7261688 Smith et al. Aug 2007 B2
7470236 Kelleher et al. Dec 2008 B1
7473222 Dewey et al. Jan 2009 B2
7481766 Lee et al. Jan 2009 B2
7522953 Kaula et al. Apr 2009 B2
7556601 Branch et al. Jul 2009 B2
7582058 Miles et al. Sep 2009 B1
7643884 Pond et al. Jan 2010 B2
7691057 Miles et al. Apr 2010 B2
7693562 Marino et al. Apr 2010 B2
7717959 William et al. May 2010 B2
7819801 Miles et al. Oct 2010 B2
7892173 Miles et al. Feb 2011 B2
7905840 Pimenta et al. Mar 2011 B2
7918891 Curran et al. Apr 2011 B1
7920922 Kaula et al. Apr 2011 B2
7935051 Miles et al. May 2011 B2
7962191 Marino et al. Jun 2011 B2
7963927 Kelleher et al. Jun 2011 B2
7991463 Kelleher et al. Aug 2011 B2
8000782 Gharib et al. Aug 2011 B2
8005535 Gharib et al. Aug 2011 B2
8016767 Miles et al. Sep 2011 B2
8021430 Michelson Sep 2011 B2
8055349 Kaula et al. Nov 2011 B2
8068912 Gharib et al. Nov 2011 B2
8114019 Miles et al. Feb 2012 B2
8133173 Miles et al. Mar 2012 B2
8137284 Miles et al. Mar 2012 B2
8172750 Miles et al. May 2012 B2
8182423 Miles et al. May 2012 B2
8187179 Miles et al. May 2012 B2
8187334 Curran et al. May 2012 B2
8192356 Miles et al. Jun 2012 B2
8192357 Miles et al. Jun 2012 B2
8244343 Gharib et al. Aug 2012 B2
8246686 Curran et al. Aug 2012 B1
8251997 Michelson Aug 2012 B2
8303458 Fukano et al. Nov 2012 B2
8303498 Miles et al. Nov 2012 B2
8303515 Pimenta et al. Nov 2012 B2
8337410 Kelleher et al. Dec 2012 B2
8343046 Miles et al. Jan 2013 B2
8343224 Lynn et al. Jan 2013 B2
8355780 Miles et al. Jan 2013 B2
8361156 Curran et al. Jan 2013 B2
8388527 Miles Mar 2013 B2
8403841 Miles et al. Mar 2013 B2
8439832 Miles et al. May 2013 B2
8489170 Marino et al. Jul 2013 B2
8500634 Miles et al. Aug 2013 B2
8512235 Miles et al. Aug 2013 B2
8523768 Miles et al. Sep 2013 B2
8548579 Gharib et al. Oct 2013 B2
8550994 Miles et al. Oct 2013 B2
8556808 Miles et al. Oct 2013 B2
8562521 Miles et al. Oct 2013 B2
8574301 Curran et al. Nov 2013 B2
8591432 Pimenta et al. Nov 2013 B2
8602982 Miles et al. Dec 2013 B2
8608804 Curran et al. Dec 2013 B2
8628469 Miles et al. Jan 2014 B2
8634904 Kaula et al. Jan 2014 B2
8663100 Miles et al. Mar 2014 B2
8672840 Miles et al. Mar 2014 B2
8673005 Pimenta et al. Mar 2014 B1
8679006 Miles et al. Mar 2014 B2
8685105 Curran et al. Apr 2014 B2
8696559 Miles et al. Apr 2014 B2
8708899 Miles et al. Apr 2014 B2
8738123 Gharib et al. May 2014 B2
8740783 Gharib et al. Jun 2014 B2
8747307 Miles et al. Jun 2014 B2
8753270 Miles et al. Jun 2014 B2
8753271 Miles et al. Jun 2014 B1
8764649 Miles et al. Jul 2014 B2
8768450 Gharib et al. Jul 2014 B2
8780899 Tillman et al. Jul 2014 B2
8812116 Kaula et al. Aug 2014 B2
8814940 Curran et al. Aug 2014 B2
8821396 Miles et al. Sep 2014 B1
8915846 Miles et al. Dec 2014 B2
8942801 Miles et al. Jan 2015 B2
8945004 Miles et al. Feb 2015 B2
8956283 Miles et al. Feb 2015 B2
8958869 Kelleher et al. Feb 2015 B2
8977352 Gharib et al. Mar 2015 B2
9014776 Marino et al. Apr 2015 B2
9037250 Kaula et al. May 2015 B2
9180021 Curran et al. Nov 2015 B2
9186261 Pimenta et al. Nov 2015 B2
9204871 Miles et al. Dec 2015 B2
9265493 Miles et al. Feb 2016 B2
9301743 Miles et al. Apr 2016 B2
9314152 Pimenta et al. Apr 2016 B2
9387090 Arnold et al. Jul 2016 B2
9456783 Kaula et al. Oct 2016 B2
9468405 Miles et al. Oct 2016 B2
9474627 Curran et al. Oct 2016 B2
9486329 Pimenta et al. Nov 2016 B2
9572562 Miles et al. Feb 2017 B2
9610071 Miles et al. Apr 2017 B2
9636233 Arnold et al. May 2017 B2
20010037123 Hancock Nov 2001 A1
20010039949 Loubser Nov 2001 A1
20010056280 Underwood et al. Dec 2001 A1
20020007129 Marino Jan 2002 A1
20020010392 Desai Jan 2002 A1
20020013514 Brau Jan 2002 A1
20020016592 Branch et al. Feb 2002 A1
20020065481 Cory et al. May 2002 A1
20020072686 Hoey et al. Jun 2002 A1
20020077632 Tsou Jun 2002 A1
20020123744 Reynard Sep 2002 A1
20020123780 Grill et al. Sep 2002 A1
20020147387 Paolitto et al. Oct 2002 A1
20020161415 Cohen et al. Oct 2002 A1
20020193843 Hill et al. Dec 2002 A1
20030032966 Foley et al. Feb 2003 A1
20030070682 Wilson et al. Apr 2003 A1
20030083688 Simonson May 2003 A1
20030105503 Marino Jun 2003 A1
20030105528 Shimp et al. Jun 2003 A1
20030109928 Pasquet et al. Jun 2003 A1
20030139648 Foley et al. Jul 2003 A1
20030149341 Clifton Aug 2003 A1
20030225405 Weiner Dec 2003 A1
20030236544 Lunsford et al. Dec 2003 A1
20040181165 Hoey et al. Sep 2004 A1
20040199084 Kelleher et al. Oct 2004 A1
20040225228 Ferree Nov 2004 A1
20040230191 Frey et al. Nov 2004 A1
20050004593 Simonson Jan 2005 A1
20050004623 Miles et al. Jan 2005 A1
20050033380 Tanner et al. Feb 2005 A1
20050060006 Pflueger et al. Mar 2005 A1
20050075578 Gharib et al. Apr 2005 A1
20050080320 Lee et al. Apr 2005 A1
20050149035 Pimenta et al. Jul 2005 A1
20050149054 Gorek Jul 2005 A1
20050182454 Gharib et al. Aug 2005 A1
20050192575 Pacheco Sep 2005 A1
20050203538 Lo et al. Sep 2005 A1
20050228232 Gillinov et al. Oct 2005 A1
20050277812 Myles Dec 2005 A1
20060025703 Miles et al. Feb 2006 A1
20060052826 Kim et al. Mar 2006 A1
20060052828 Kim et al. Mar 2006 A1
20060069315 Miles et al. Mar 2006 A1
20060224078 Hoey et al. Oct 2006 A1
20060235529 Ralph et al. Oct 2006 A1
20060247658 Pond, Jr. et al. Nov 2006 A1
20070016097 Farquhar et al. Jan 2007 A1
20070021682 Gharib et al. Jan 2007 A1
20070049931 Justis et al. Mar 2007 A1
20070049962 Marino et al. Mar 2007 A1
20070072475 Justin et al. Mar 2007 A1
20070100212 Pimenta et al. May 2007 A1
20070198062 Miles et al. Aug 2007 A1
20070208228 Pavento et al. Sep 2007 A1
20070260317 Ankney et al. Nov 2007 A1
20070270842 Bankoski et al. Nov 2007 A1
20070293782 Marino Dec 2007 A1
20080058606 Miles et al. Mar 2008 A1
20080058838 Steinberg Mar 2008 A1
20080064976 Kelleher et al. Mar 2008 A1
20080064977 Kelleher et al. Mar 2008 A1
20080065135 Marino et al. Mar 2008 A1
20080065144 Marino et al. Mar 2008 A1
20080065178 Kelleher et al. Mar 2008 A1
20080071191 Kelleher et al. Mar 2008 A1
20080077138 Cohen et al. Mar 2008 A1
20080097164 Miles et al. Apr 2008 A1
20080103601 Biro et al. May 2008 A1
20080146885 Protopsaltis Jun 2008 A1
20080183214 Copp et al. Jul 2008 A1
20080221394 Melkent et al. Sep 2008 A1
20080288077 Reo et al. Nov 2008 A1
20080300465 Feigenwinter et al. Dec 2008 A1
20090030519 Falahee Jan 2009 A1
20090124860 Miles et al. May 2009 A1
20090132049 Carver et al. May 2009 A1
20090138050 Ferree May 2009 A1
20090138090 Hurlbert et al. May 2009 A1
20090192403 Gharib et al. Jul 2009 A1
20090204016 Gharib et al. Aug 2009 A1
20100069783 Miles et al. Mar 2010 A1
20100106251 Kast Apr 2010 A1
20100130827 Pimenta et al. May 2010 A1
20100152603 Miles et al. Jun 2010 A1
20100160738 Miles et al. Jun 2010 A1
20100174146 Miles Jul 2010 A1
20100174148 Miles et al. Jul 2010 A1
20100228350 Gornet et al. Sep 2010 A1
20110046448 Paolitto et al. Feb 2011 A1
20110218631 Woodburn, Sr. et al. Sep 2011 A1
20110313530 Gharib et al. Dec 2011 A1
20120238822 Miles Sep 2012 A1
20120238893 Farquhar et al. Sep 2012 A1
20130331943 Arnold et al. Dec 2013 A1
20140235950 Miles et al. Aug 2014 A1
20140288374 Miles et al. Sep 2014 A1
20140288375 Miles et al. Sep 2014 A1
20150150693 Gharib et al. Jun 2015 A1
20150157227 Kelleher et al. Jun 2015 A1
20150157228 Marino et al. Jun 2015 A1
20150282948 Arnold et al. Oct 2015 A1
20160120530 Miles et al. May 2016 A1
20160174958 Miles et al. Jun 2016 A1
20160174959 Miles et al. Jun 2016 A1
20160192921 Pimenta et al. Jul 2016 A1
20160374613 Kaula et al. Dec 2016 A1
20170007421 Curran et al. Jan 2017 A1
20170020503 Miles et al. Jan 2017 A1
20170027712 Pimenta et al. Feb 2017 A1
20170143514 Gharib et al. May 2017 A1
20170143515 Gharib et al. May 2017 A1
20170156580 Miles et al. Jun 2017 A1
20170164938 Miles et al. Jun 2017 A1
20170172558 Miles et al. Jun 2017 A1
Foreign Referenced Citations (44)
Number Date Country
299 08 259 Jul 1999 DE
100 48 790 Apr 2002 DE
0 334 116 Sep 1989 EP
0 567 424 Oct 1993 EP
0 972 538 Jan 2000 EP
1 002 500 May 2000 EP
2 795 624 Jan 2001 FR
793186 May 1990 JP
10-14928 Mar 1996 JP
3019990007098 Nov 1999 KR
9428824 Dec 1994 WO
9700702 Jan 1997 WO
9823324 Jun 1998 WO
9952446 Oct 1999 WO
0027291 May 2000 WO
0038574 Jul 2000 WO
0044288 Aug 2000 WO
WO-0062660 Oct 2000 WO
0066217 Nov 2000 WO
0067645 Nov 2000 WO
0108563 Feb 2001 WO
0137728 May 2001 WO
0160263 Aug 2001 WO
02054960 Jul 2002 WO
02058780 Aug 2002 WO
0271953 Sep 2002 WO
0287678 Nov 2002 WO
03005887 Jan 2003 WO
03026482 Apr 2003 WO
03037170 May 2003 WO
WO-03084398 Oct 2003 WO
WO-2004064634 Aug 2004 WO
05013805 Feb 2005 WO
05030318 Apr 2005 WO
06042241 Apr 2006 WO
06066217 Jun 2006 WO
WO-2007035925 Mar 2007 WO
WO-2007136784 Nov 2007 WO
WO-2009055034 Apr 2009 WO
WO-2011059491 May 2011 WO
WO-2011059498 May 2011 WO
WO-2012026981 Mar 2012 WO
WO-2012103254 Aug 2012 WO
WO-2013028571 Feb 2013 WO
Non-Patent Literature Citations (87)
Entry
510(K) No. K002677, approved by the FDA on Nov. 13, 2000, 634 pages.
510(K) No. K013215, approved by the FDA on Oct. 16, 2001, 376 pages.
Co-pending U.S. Appl. No. 15/498,296, filed Apr. 26, 2017.
Co-pending U.S. Appl. No. 90/013,464, filed Mar. 6, 2015.
Co-pending U.S. Appl. No. 90/013,546, filed Jul. 8, 2015.
Co-pending U.S. Appl. No. 90/013,605, filed Oct. 8, 2015.
Co-pending U.S. Appl. No. 95/001,247, filed Oct. 27, 2009.
Co-pending U.S. Appl. No. 95/001,888, filed Feb. 9, 2012.
Co-pending U.S. Appl. No. 95/001,890, filed Feb. 9, 2012.
European Search Report dated Apr. 7, 2015 for EP Application No. 12826211.0.
European Search Report dated Aug. 2, 2012 for EP Application No. 12001129.1.
European Search Report dated Sep. 28, 2009 for EP Application No. 02778359.6.
In re: NuVasive, Inc., in 2015-1670 decided on Dec. 7, 2016, 13 Pages.
In re: NuVasive, Inc., in 2015-1672, 2015-1673 decided on Nov. 9, 2016, 16 Pages.
In re: NuVasive, Inc., in 2015-1838 signed on May 10, 2017, 2 Pages.
In re: NuVasive, Inc., in 2015-1839, 2015-1840 signed on May 10, 2017, 2 Pages.
In re: NuVasive, Inc., in 2015-1841 decided on May 31, 2017, 16 Pages.
In re: NuVasive, Inc., in 2015-1842, 2015-1843 signed on May 10, 2017, 2 Pages.
In re: Warsaw Orthopedic, Inc. In 15-1050 filed Oct. 14, 2014.
In re: Warsaw Orthopedic, Inc. In 15-1058 filed Oct. 17, 2014.
International Search Report dated Jan. 12, 2011 for International Application No. PCT/US2010/002960.
International Search Report dated Feb. 9, 2005 for International Application PCT/US2004/031768.
International Search Report dated Mar. 27, 2003 for International Application PCT/US2002/022247.
International Search Report dated Jun. 5, 2003 for International Application No. PCT/US2002/030617.
International Search Report dated Jul. 24, 2012 for International Application No. PCT/US2012/022600.
International Search Report dated Oct. 29, 2012 for International Application No. PCT/US2012/051480.
International Search Report dated Dec. 13, 2011 for International Application No. PCT/US2011/001489.
International Search Report dated Dec. 24, 2008 for International Application No. PCT/US2008/012121.
International Search Report dated Mar. 23, 2011 for International Application No. PCT/US2010/002951.
Medtronic Sofamor Danek “UNION TM / UNION-L TM Anterior & Lateral Impacted Fusion Devices: Clear choice of stabilization,” Medtronic Sofamor Danek, 2000, 4 pages.
Notice of allowance dated Jan. 14, 2016 for U.S. Appl. No. 14/066,098.
Notice of Allowance dated Mar. 30, 2017 for U.S. Appl. No. 14/263,797.
Notice of Allowance dated Apr. 12, 2017 for U.S. Appl. No. 15/272,071.
NuVasive, Inc. v. Medtronic, Inc. in 15-1674 filed May 26, 2015, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
NuVasive, Inc. v. Medtronic, Inc. in 15-1712 filed Jun. 8, 2015, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
NuVasive, Inc. v. Warsaw Orthopedic, Inc. in 15-1049 filed Oct. 14, 2014, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
NuVasive Vertebral Body Access System, 2000, 1 page.
Office Action dated Jan. 11, 2012 for U.S. Appl. No. 11/982,185.
Office Action dated Jan. 12, 2012 for U.S. Appl. No. 11/489,020.
Office Action dated Jan. 21, 2011 for U.S. Appl. No. 11/982,185.
Office Action dated Feb. 26, 2016 for U.S. Appl. No. 14/622,585.
Office Action dated Mar. 16, 2009 for U.S. Appl. No. 11/489,020.
Office Action dated Mar. 29, 2017 for U.S. Appl. No. 15/448,395.
Office Action dated Apr. 5, 2017 for U.S. Appl. No. 15/445,854.
Office Action dated Apr. 6, 2017 for U.S. Appl. No. 15/439,889.
Office Action dated Apr. 7, 2017 for U.S. Appl. No. 15/059,215.
Office Action dated Apr. 29, 2010 for U.S. Appl. No. 11/982,185.
Office Action dated May 6, 2010 for U.S. Appl. No. 11/489,020.
Office Action dated May 8, 2014 for U.S. Appl. No. 13/964,836.
Office Action dated Jun. 17, 2009 for U.S. Appl. No. 11/982,185.
Office action dated Jul. 15, 2015 for U.S. Appl. No. 14/066,098.
Office Action dated Sep. 15, 2008 for U.S. Appl. No. 11/489,020.
Office Action dated Sep. 19, 2016 for U.S. Appl. No. 14/263,797.
Office Action dated Sep. 23, 2016 for U.S. Appl. No. 14/622,585.
Office Action dated Oct. 9, 2009 for U.S. Appl. No. 11/489,020.
Office Action dated Oct. 20, 2016 for U.S. Appl. No. 14/297,369.
Office Action dated Nov. 28, 2016 for U.S. Appl. No. 14/994,640.
Office Action dated Nov. 4, 2016 for U.S. Appl. No. 14/297,438.
Office Action dated Dec. 19, 2014 for U.S. Appl. No. 13/964,836.
Office action dated Dec. 22, 2014 for U.S. Appl. No. 14/066,098.
Patent Trial and Appeal Board Decision from IPR 2014-00087, dated Apr. 8, 2014, 31 pages. Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00504 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00506 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00507 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2013-00508 filed Aug. 14, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00034 filed Oct. 8, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00035 filed Oct. 8, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00071 filed Oct. 16, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00073 filed Oct. 18, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00074 filed Oct. 18, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00075 filed Oct. 21, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00076 filed Oct. 21, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00081 filed Oct. 22, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00087 filed Oct. 22, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by Medtronic, Inc. in IPR2014-00487 filed Mar. 5, 2014, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00206 filed Mar. 22, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00208 filed Mar. 22, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00395 filed Jun. 27, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2013-00396 filed Jun. 27, 2013, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Petition for Inter Partes Review by NuVasive, Inc. in IPR2015-00502 filed Dec. 24, 2014, Individual documents of the referenced court case are not being submitted herewith, as Applicant understands the documents to be readily accessible by the Examiner. However, Applicant can provide any of the documents upon request.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 12-1263 filed Mar. 15, 2012.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 12-1266 filed Mar. 15, 2012.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 13-1576 filed Aug. 21, 2013.
Warsaw Orthopedic, Inc. v. NuVasive, Inc. in 13-1577 filed Aug. 21, 2013.
INS-1 Guide Dec. 31, 2000, Part I.
INS-1 Guide Dec. 31, 2000, Part II.
INS-1 Guide Dec. 31, 2000, Part III.
Related Publications (1)
Number Date Country
20160192921 A1 Jul 2016 US
Provisional Applications (1)
Number Date Country
60512594 Oct 2003 US
Continuations (4)
Number Date Country
Parent 14066098 Oct 2013 US
Child 15071540 US
Parent 12983627 Jan 2011 US
Child 14066098 US
Parent 12635869 Dec 2009 US
Child 12983627 US
Parent 10967668 Oct 2004 US
Child 12635869 US